Antibodies

08 Apr 2008 U.S. Food and Drug Administration Approves ORENCIA(R) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
03 Apr 2008 Medarex Announces Ipilimumab Program Continues to Move Forward
02 Apr 2008 Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
01 Apr 2008 Pfizer Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma
31 Mar 2008 Phase II results for CDP791 in non-small cell lung cancer support further clinical development
31 Mar 2008 Crucell Announces Start of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US
28 Mar 2008 Seattle Genetics Expands SGN-35 Clinical Program with Initiation of Second Phase I Trial
27 Mar 2008 Thallion provides update on Shigamabs (R) program
27 Mar 2008 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
26 Mar 2008 DAIICHI SANKYO Extends Alliance with MorphoSys for Use of HuCAL GOLD to Develop Novel Antibody Therapies
20 Mar 2008 Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers
20 Mar 2008 CHMP Upholds Negative Opinion for the EU Application for Cimzia® in the Treatment of Crohn's Disease
20 Mar 2008 Seattle Genetics Initiates SGN-33 Clinical Trial in Combination with Revlimid(R) for Myelodysplastic Syndromes (MDS)
20 Mar 2008 Zevalin(R) Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
19 Mar 2008 MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
18 Mar 2008 Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
17 Mar 2008 Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
17 Mar 2008 MorphoSys Obtains Agreement for Production of Antibody Material in MOR202 Program with Crucell and DSM
16 Mar 2008 GlaxoSmithKline's Bosatria shows promise in late-stage study
13 Mar 2008 Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
13 Mar 2008 BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies
12 Mar 2008 Amgen Statement on Successful Outcome of Romiplostim Panel Meeting
12 Mar 2008 Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
10 Mar 2008 iCo Therapeutics Provides iCo-008 Phase II Clinical Update
05 Mar 2008 Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top